Search details
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Article
in English
| MEDLINE | ID: mdl-37931632
2.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38634928
3.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37248424
4.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37676282
5.
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Int J Mol Sci
; 24(11)2023 May 23.
Article
in English
| MEDLINE | ID: mdl-37298116
6.
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(10): 1287-1296, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36096156
7.
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy.
Cancer
; 128(4): 719-726, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-34706060
8.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Article
in English
| MEDLINE | ID: mdl-36180954
9.
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study.
Int J Mol Sci
; 23(10)2022 May 21.
Article
in English
| MEDLINE | ID: mdl-35628597
10.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34499874
11.
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Curr Oncol Rep
; 23(12): 147, 2021 11 08.
Article
in English
| MEDLINE | ID: mdl-34748099
12.
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.
Br J Cancer
; 123(4): 644-656, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32493992
13.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32735386
14.
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas.
Radiol Med
; 125(10): 951-960, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32306201
15.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29846246
16.
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.
Eur J Nucl Med Mol Imaging
; 44(7): 1155-1164, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28110346
17.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
BMC Cancer
; 17(1): 493, 2017 Jul 19.
Article
in English
| MEDLINE | ID: mdl-28724419
18.
RAMES study: is there really a role for VEGF inhibition in mesothelioma? - Authors' reply.
Lancet Oncol
; 22(12): e533, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34856143
19.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26776493
20.
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
Invest New Drugs
; 33(1): 159-68, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25294187